Ann Pope

613 total citations
13 papers, 228 citations indexed

About

Ann Pope is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ann Pope has authored 13 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Ann Pope's work include Bladder and Urothelial Cancer Treatments (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Prostate Cancer Treatment and Research (5 papers). Ann Pope is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Prostate Cancer Treatment and Research (5 papers). Ann Pope collaborates with scholars based in United Kingdom and Canada. Ann Pope's co-authors include Lucinda Billingham, Nicholas D. James, Sarah Pirrie, Wei Shen Tan, Laura Buckley, John D. Kelly, Vijay Sangar, Rupesh I. Bhatt, Sanjeev Madaan and Adam Devall and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Ann Pope

12 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Pope United Kingdom	6	171	77	64	52	34	13	228
Ali̇ Şahi̇n Türkiye	6	242 1.4×	135 1.8×	86 1.3×	23 0.4×	22 0.6×	16	319
Kensuke Bekku Japan	9	105 0.6×	24 0.3×	114 1.8×	41 0.8×	12 0.4×	57	221
Stefan Steurer Germany	5	65 0.4×	64 0.8×	182 2.8×	21 0.4×	19 0.6×	11	241
Nobutaka Nishimura Japan	8	169 1.0×	36 0.5×	75 1.2×	41 0.8×	6 0.2×	46	240
James C. Brien United States	5	360 2.1×	151 2.0×	105 1.6×	56 1.1×	9 0.3×	6	399
Richmond Owusu United States	8	178 1.0×	71 0.9×	38 0.6×	37 0.7×	5 0.1×	8	281
Nimrod Barashi United States	6	75 0.4×	34 0.4×	39 0.6×	23 0.4×	10 0.3×	12	149
Filippo Sogni Italy	8	306 1.8×	169 2.2×	101 1.6×	39 0.8×	3 0.1×	16	383
François Xavier Nouhaud France	6	131 0.8×	45 0.6×	49 0.8×	29 0.6×	5 0.1×	9	153
Yu-Tang Chang Taiwan	12	242 1.4×	14 0.2×	53 0.8×	93 1.8×	7 0.2×	26	332

Countries citing papers authored by Ann Pope

Since Specialization

Citations

This map shows the geographic impact of Ann Pope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Pope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Pope more than expected).

Fields of papers citing papers by Ann Pope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Pope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Pope. The network helps show where Ann Pope may publish in the future.

Co-authorship network of co-authors of Ann Pope

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Pope. A scholar is included among the top collaborators of Ann Pope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Pope. Ann Pope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

James, Nicholas D., Sarah Pirrie, Ana Hughes, et al.. (2025). LBA111 Randomized comparison of upfront magnetic resonance imaging versus transurethral resection for staging new bladder cancers: Final survival analysis from the BladderPath trial. Annals of Oncology. 36. S1652–S1652.

James, Nicholas D., Sarah Pirrie, James W.F. Catto, et al.. (2024). Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT. Health Technology Assessment. 28(42). 1–65. 1 indexed citations

James, Nicholas D., Ann Pope, Amisha Desai, et al.. (2022). Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer. SHILAP Revista de lepidopterología. 3(6). 484–493. 3 indexed citations

Bryan, Richard T., Sarah Pirrie, Ana Hughes, et al.. (2021). Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study. European Urology. 80(1). 12–15. 38 indexed citations

Parsons, Helen, Ana Hughes, Ann Pope, et al.. (2020). Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial. Pilot and Feasibility Studies. 6(1). 165–165. 3 indexed citations

James, Nicholas D., Sarah Pirrie, Ana Hughes, et al.. (2020). Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath study.. Journal of Clinical Oncology. 38(6_suppl). 446–446. 3 indexed citations

Tan, Wei Shen, Anesh Panchal, Laura Buckley, et al.. (2018). Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial. European Urology. 75(1). 63–71. 107 indexed citations

Tan, Wei Shen, Laura Buckley, Adam Devall, et al.. (2017). Radiofrequency-induced thermo-chemotherapy effect plus mitomycin versus a second course of bacillus Calmette-Guérin (BCG) or institutional standard in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance BCG therapy (HYMN): A phase III, open-label, randomised controlled trial. European Urology Supplements. 16(3). e1156–e1157. 1 indexed citations

James, Nicholas D., Sarah Pirrie, Ann Pope, et al.. (2016). TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer. Health Technology Assessment. 20(53). 1–288. 36 indexed citations

10.

James, Nicholas D., Lazaros Andronis, Ilias Goranitis, et al.. (2015). Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer. (ISRCTN 12808747) TRAPEZE.. Journal of Clinical Oncology. 33(15_suppl). e16108–e16108. 1 indexed citations

11.

James, Nicholas D., Sarah Pirrie, Darren Barton, et al.. (2013). Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747).. Journal of Clinical Oncology. 31(18_suppl). LBA5000–LBA5000. 20 indexed citations

12.

James, Nicholas D., Sarah Pirrie, Darren Barton, et al.. (2013). Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial trapeze trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747).. Journal of Clinical Oncology. 31(15_suppl). LBA5000–LBA5000. 5 indexed citations

13.

Nathan, Malavika, et al.. (1994). Prolapsed ureterocele: a rare vulval mass. British Journal of Urology. 73(1). 109–110. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact